Nahid Farooq Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3777 Coolheights Dr, Rancho Palos Verdes, CA 90275 Phone: 310-377-7736 |
Megumi Ichikawa-chang, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 27432 Larchbluff Dr, Rancho Palos Verdes, CA 90275 Phone: 626-688-9036 |
Mr. Dexter Jay Jefferson Jr., LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 28924 S Western Ave Ste 225, Rancho Palos Verdes, CA 90275 Phone: 310-593-4996 |
Ms. Ann Christensen, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 28631 S Western Ave, Suite 107, Rancho Palos Verdes, CA 90275 Phone: 310-463-4538 |
Mrs. Eleanor L. Huang, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 29135 Indian Valley Rd, Rancho Palos Verdes, CA 90275 Phone: 310-377-0411 |
Mrs. Alicia Ann Macgowan, L.C.S.W. Clinical Social Worker Medicare: May Accept Medicare Assignments Practice Location: 2138 Fairhill Dr, Rancho Palos Verdes, CA 90275 Phone: 310-508-9531 |
James Bertolina, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3713 Hightide Dr, Rancho Palos Verdes, CA 90275 Phone: 310-265-0446 |
Ms. Nelly Bertolina, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3713 Hightide Dr, Rancho Palos Verdes, CA 90275 Phone: 310-265-0446 |
News Archive
An investigational drug for the treatment of sickle cell disease is showing early promise in clinical trials for impacting biomarkers of the disease in patients, reported UConn School of Medicine researchers at the European Hematology Association Congress in Amsterdam this week.
Human papillomavirus (HPV) status is a strong predictor of prognosis for patients with oropharyngeal carcinoma (OPC), but the current staging system does not adequately account for biological and clinical differences between HPV-positive OPC and HPV-negative OPC, commonly caused by alcohol and tobacco use.
JenaValveā¢ Technology, Inc., a medical device company specializing in developing transcatheter aortic valve implantation (TAVI) systems, announced today a significant clinical milestone: the first-ever successful transcatheter implantation of a 27mm transapical aortic valve prosthesis.
Congenital heart experts from Spectrum Health Helen DeVos Children's Hospital have successfully integrated two common imaging techniques to produce a three-dimensional anatomic model of a patient's heart.
› Verified 9 days ago